Today I am thrilled to announce the launch of our next landmark research investment, PASS-01: a clinical trial that will finally address the diverse nature of this disease and provide personalized treatment options for advanced pancreatic cancer patients....
What you Need to Know About Wills in 40 Minutes On Demand Webinar With so much to consider, we know creating or updating your will can be a daunting task. That’s why we asked Certified Executor Advisor Walter Viner to share some important advice with our...
OUR IMPACT: 2019 OUR IMPACT: 2019 A Year In Review 2019 was a year of growth, inspiration and tenacity. We set out to make significant research and awareness investments, grow our support programs, and further our partnerships to deliver services and...
Community fundraiser adapts amidst global pandemic By Ali Schofield Dedicated. Resilient. Compassionate. These are just a few words that describe Pam Kosolofski, a steadfast champion of progress for pancreatic cancer patients – even amidst a global pandemic. Each...
For several months the COVID-19 crisis has caused many research projects to slow, but Pancreatic Cancer Canada’s research program has not been idle. We have taken this time to quietly prepare for our next big project, because even in the midst of...
Pancreatic Cancer Clinical Trial Launches During Pandemic With Aim to Change Standard of Care for Patients TORONTO, ON, July 15, 2020 – Pancreatic Cancer Canada announced today the launch of NeoPancONE, a Phase II clinical trial that aims to be a curative strategy for...
Recent Comments